Compounds > dipyrone

dipyrone and hydroxyurea

dipyrone has been researched along with hydroxyurea in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Alexandre-Moreira, MS; Chung, M; Costa, FF; dos Santos, JL; Franco-Penteado, CF; Gambero, S; Kutlar, A; Lanaro, C; Lima, LM; Meiler, SE; Wade, M; Yerigenahally, S1
Bosquesi, PL; Cerecetto, H; Chelucci, RC; Chung, MC; Costa, FF; Dos Santos, JL; Gambero, S; González, M; Lanaro, C; Lima, LM; Reis, JS1

Other Studies

4 other study(ies) available for dipyrone and hydroxyurea

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Design, synthesis, and pharmacological evaluation of novel hybrid compounds to treat sickle cell disease symptoms.
    Journal of medicinal chemistry, 2011, Aug-25, Volume: 54, Issue:16

    Topics: Acetic Acid; Analgesics; Anemia, Sickle Cell; Animals; Anti-Inflammatory Agents; Antisickling Agents; Capsaicin; Colic; Drug Design; Ear; Edema; Female; Male; Mice; Mice, Transgenic; Models, Chemical; Molecular Structure; Peritonitis; Thalidomide; Thioglycolates; Tumor Necrosis Factor-alpha

2011
Design, synthesis, and pharmacological evaluation of novel hybrid compounds to treat sickle cell disease symptoms. part II: furoxan derivatives.
    Journal of medicinal chemistry, 2012, Sep-13, Volume: 55, Issue:17

    Topics: Anemia, Sickle Cell; Drug Design; Drug Evaluation, Preclinical; Humans; Nitric Oxide Donors; Oxadiazoles; Polymerase Chain Reaction

2012